FIELD: medicine, pharmaceutical industry.
SUBSTANCE: the present innovation deals with developing new medicinal preparations for treating urogenital diseases. The suggested preparation for treating prostatic diseases designed as a suppository that contains the complex of bioregulatory peptides of cattle prostate as a powder with the content of water-soluble peptides being 20%, not less and the foundation, moreover, antimicrobial preparation being the antibiotic or anti-viral preparation, or anti-protozoan preparation, or the mixture of antibiotic and anti-protozoan preparation taken at 1:1 ratio, or the mixture of anti-viral and anti-protozoan preparation taken at 1:1 ratio and the foundation at the following ratio of the components, g/suppository: complex of bioregulatory peptides of cattle prostate 0.05-0.4; antimicrobial preparation 0.7, not more; the foundation - sufficient quantity to obtain the suppository of 2.15-2.35 g weight. The suggested preparation in the form of suppository is of high level of organotropic activity and high level of antimicrobial action that enables to implement etiotropic and pathogenetic therapy of bacterial prostatitis. The innovation provides the action upon an agent and all pathological processes in the affected organ. The innovation enables to treat bacterial prostatic inflammation and that of functionally associated organs.
EFFECT: higher efficiency of therapy.
4 cl, 132 ex, 32 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR TREATING PROSTATE DISEASES (VERSIONS) | 2009 |
|
RU2430733C2 |
PREPARATION FOR TREATMENT OF PROSTATIC GLAND DISEASES MADE IN FORM OF A SUPPOSITORY | 2019 |
|
RU2752588C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING DISEASES OF LOWER PART OF GENITOURINARY SYSTEM | 2010 |
|
RU2428173C1 |
AGENT "VITAPROST" FOR PROSTATE GLAND DISEASE TREATMENT | 1996 |
|
RU2112504C1 |
MEDICAL PRODUCT AND MEDICINAL COMPOSITION FOR MANUFACTURING THEREOF | 2008 |
|
RU2372933C1 |
MEANS FOR TREATMENT OF CHRONIC PROSTATITIS | 2007 |
|
RU2342940C1 |
RECTAL MEANS FOR TREATING CHRONIC PROSTATITIS | 1999 |
|
RU2160114C1 |
RECTAL MEDICINAL AGENT FOR CORRECTION OF SPERMATOGENESIS DISORDERS IN MALE INFERTILITY | 2017 |
|
RU2686334C2 |
AGENT FOR TREATMENT OF PROSTATE DISEASE | 2005 |
|
RU2278681C1 |
AGENT FOR CHRONIC PROSTATITIS HEALING | 2000 |
|
RU2179032C1 |
Authors
Dates
2007-08-27—Published
2005-11-08—Filed